Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02506855

Intraoperative Transversus Abdominis Plane Block for Gynecologic Surgery (GYNTAP)

Intraoperative Transversus Abdominis Plane Block for Gynecologic Surgery (GYNTAP): Modifying an Existing Technique for Ease of Administration and Increased Accuracy

Status
Withdrawn
Phase
Phase 3
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Mississippi Medical Center · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study attempts to learn about the effectiveness of a modification to the Transversus Abdominis Plane (TAP) block that works by anaesthetizing the sensory afferents of the abdominal wall postoperatively using ultrasound guidance. The investigators want to see if regional blocks placed by the surgeon intraoperatively to assure regional anesthetic spread in the appropriate plane could reduce error and improve postoperative recovery.

Detailed description

This study is a prospective, randomized blinded study that investigates the efficacy of a transversus abdominis plane block under direct view. In this pilot study involving gynecologic patients undergoing open (abdominal wall incision either vertically or horizontally) hysterectomy or other related gynecologic surgery, the investigators will use ropivacaine versus saline for the placebo control group, which in both groups involves injection of agent directly into the appropriate fascial layers prior to abdominal wall closure. Efficacy is to be assessed via measurement of pain scores, nausea and vomiting, and opioid consumption in both participant groups. The number of dermatomes which are blocked in both participant groups during the first 24 hours following surgery will be recorded.

Conditions

Interventions

TypeNameDescription
DRUGRopivacaine
OTHERPlacebo
PROCEDURETransversus Abdominis Plane Block

Timeline

Start date
2015-06-01
Primary completion
2016-01-01
Completion
2016-06-01
First posted
2015-07-23
Last updated
2016-05-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02506855. Inclusion in this directory is not an endorsement.